Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy: a Randomized Cross-over Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Aerosol Particle Concentrations With Size of <0.3 Micrometer at 1 Foot Away From the Patient
Study Overview
Brief Summary
For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.
Detailed Description
The transmission route of the SARS-CoV-2 virus remains controversial, and concerns persist of potentially increased virus transmission when utilizing high-flow devices and aerosol devices among COVID-19 patients. For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk of tracheostomy during spontaneous breathing has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Other
- Masking
- Single (Outcomes Assessor)
Masking Description
the device utilized in the study will be labeled as 1,2,3,4 and 5, the investigator who performed the statistical analysis will be blinded for the device
Eligibility Criteria
- Ages
- 18 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •tracheostomy;
- •able to spontaneous breathing without ventilator support
Exclusion Criteria
- •confirmed diagnosis of COVID-19 within recent two weeks;
- •non-English speaking;
- •refuse to participate in the study;
- •palliative care;
- •receiving ECMO;
- •unable to connect with tracheostomy adapter, such as laryngectomy tube
Arms & Interventions
high-flow high humidity oxygen device with tracheostomy adapter
This device provides high-flow gas to tracheostomy patients with heat and humidification. A special adapter is used to connect the tracheostomy tube and circuit.
Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)
large-volume nebulizer (cool aerosol) with trach collar
This device is the conventional device that is commonly utilized to provide humidification for spontaneous breathing patients with tracheostomy.
Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)
Venturi-adapter with trach collar
This device did not provide any humidification but only oxygen
Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)
large-volume nebulizer (cool aerosol) with T-piece and a filter
this device is added with a filter, in order to reduce aerosol particle concentrations in the surrounding environment
Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)
high-flow high humidity device with a scavenger or a surgical mask
this device is added with a scavenger or a surgical mask over the adapter, in order to reduce aerosol particle concentrations in the surrounding environment
Intervention: high-flow high humidity oxygen device with tracheostomy adapter (Device)
Outcomes
Primary Outcomes
Aerosol Particle Concentrations With Size of <0.3 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Aerosol Particle Concentrations With Size of 1-3 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Aerosol Particle Concentrations With Size of 0.3-0.5 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Aerosol Particle Concentrations With Size of 5-10 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Aerosol Particle Concentrations With Size of 3-5 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Aerosol Particle Concentrations With Size of 0.5-1 Micrometer at 1 Foot Away From the Patient
Time Frame: 5 minutes after using the device
aerosol particle concentrations (the concentrations of particles inside the room air, the unit is particles per cubic meters) at 1 foot away from the patient
Secondary Outcomes
- Patient Comfort With Different Oxygen Devices(5 minutes after using the device)
Investigators
Jie Li
Associate professor
Rush University Medical Center
